Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Brittany T. Straka"'
Autor:
Claudia E. Ramirez, Elizabeth Stone, Chang Yu, Aleena Banerji, Nancy J. Brown, Brittany T. Straka, James Brian Byrd, Hui Nian, Alencia Woodard-Grice
Background The B 2 receptor antagonist icatibant is approved for treatment of attacks of hereditary angioedema. Icatibant has been reported to decrease time-to-resolution of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema in 1 stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7ca1bdb83cfe8c4144f8e83e1175237
https://europepmc.org/articles/PMC5705179/
https://europepmc.org/articles/PMC5705179/
Publikováno v:
JAMA Dermatology. 154:1221
This randomized clinical trial assesses whether treatment with the neurokinin 1 receptor antagonist aprepitant decreases pruritus vs placebo in patients with Sézary syndrome.
Autor:
James Brian Byrd, Nian Hui, Alencia Woodard-Grice, Elizabeth Stone, Nancy J. Brown, Chang Yu, Aleena Banerji, Claudia E. Ramirez, Brittany T. Straka
Publikováno v:
Hypertension. 68
The B2 receptor antagonist icatibant is approved for treatment of attacks of hereditary angioedema. Icatibant has been reported to decrease time-to-resolution of ACE inhibitor-associated angioedema in one study of European patients. Patients with ACE
Autor:
Candace D. McNaughton, Brittany T. Straka, Hui Nian, Eduardo Dias, Richard M. Caprioli, Chang Yu, Brian Hachey, Nancy J. Brown
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 937
Cardiovascular drugs are the most commonly prescribed medications. Some prior assays successfully detect cardiovascular drugs among multiple classes using a single sample. Here, we develop an assay to detect a broad range of cardiovascular drug class
Autor:
Steven R. Feldman, Thomas H. Wiser, Stephen E. Helms, Eliot N. Mostow, Robert T. Brodell, Brittany T. Straka
Publikováno v:
Journal of the American Academy of Dermatology. 63(6)
Autor:
Chang Yu, James Brian Byrd, Alencia Woodard-Grice, Nancy J. Brown, Guillaume Paré, Brittany T. Straka, Catherine A. McCarty, Koon K. Teo, Tina V. Hartert, Hui Nian, Elizabeth Stone, Gary Steven, Chantel D. Sloan
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 1:468-473.e4
Background The incidence of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema is increased in patients with seasonal allergies. Objective We tested the hypothesis that patients with ACE inhibitor-associated angioedema present during